The classification and treatment of antibody-mediated renal allograft injury: Where do we stand?
The classification and treatment of antibody-mediated renal allograft injury: Where do we stand?
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Since the acceptance of the detection of C4d in allografts as a reliable tool to mark a humoral alloresponse, de novo antibody-induced graft injury has attracted much attention. Antibodies and B cells are the new frontier in transplantation. At this juncture carefully designed studies are critical in order to gain solid diagnostic, therapeutic, and...
Alternative Titles
Full title
The classification and treatment of antibody-mediated renal allograft injury: Where do we stand?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68378952
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68378952
Other Identifiers
ISSN
0085-2538
E-ISSN
1523-1755
DOI
10.1038/sj.ki.5002003
